中文版 | English

在结果中检索

YIC-IR

浏览/检索结果: 共2条，第1-2条 帮助

已选(0)清除 条数/页：   排序方式：
Results of the phase IIa study to evaluate the efficacy and safety of rezivertinib (BPI-7711) for the first-line treatment of locally advanced or metastatic EGFR mutation from a phase I 期刊论文
BMC MEDICINE, 2023, 卷号: 21, 期号: 1
作者:  Yuankai Shi;  Jianying Zhou;  Yanqiu Zhao;  Bo Zhu;  Liangming Zhang;  Xingya Li;  Jian Fang;  Jianhua Shi;  Zhixiang Zhuang;  Sheng Yang;  Donglin Wang;  Huiqing Yu;  Longzhen Zhang;  Rongsheng Zheng;  Michael Greco;  Tingting Wang
收藏  |  浏览/下载：15/0  |  提交时间：2024/05/07
Efficacy and safety of iruplinalkib (WX-0593) in ALK -positive crizotinib-resistant advanced non-small cell lung cancer patients: a single-arm, multicenter phase II study (INTELLECT) 期刊论文
BMC MEDICINE, 卷号: 21, 期号: 1
作者:  Yuankai Shi;  Jianhua Chen;  Helong Zhang;  Zhihong Zhang;  Yiping Zhang;  Zhehai Wang;  Shucai Zhang;  Jian Zhao;  Chunling Liu;  Xiuwen Wang;  Yanqiu Zhao;  Changlu Hu;  Lei Yang;  Xuezhi Hao;  Lin Wang;  Yunpeng Liu;  Yan Yu;  Jun Zhao;  Mengzhao Wang;  Liangming Zhang;  Sanyuan Sun;  Yanping Hu;  Kangsheng Gu;  Xiaosheng Hang;  Jinlu Shan;  Yu Zhang;  Bangxian Tan;  Weihua Yang;  Runxiang Yang;  Meimei Si;  Huaize Geng;  Hui Li;  Xiaoyan Kang
收藏  |  浏览/下载：41/0  |  提交时间：2024/05/07